Latest News and Press Releases
Want to stay updated on the latest news?
-
Stockholm - Tele2 AB, ("Tele2"), (Stockholm Stock Exchange: TEL2 A and TEL2 B), Europe's leading alternative telecom operator, today completed the divestment of Tele2 Denmark to Telenor. Telenor...
-
AS Eesti Ehitus Announcement July 12, 2007 Announcements released by AS Eesti Ehitus According to § 135 section 4 of the Securities Market Act of Estonia...
-
MELVILLE, NY--(Marketwire - July 12, 2007) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported today that physicians who use the FONAR UPRIGHT™ MRI are testifying...
-
* New Contract in the Middle East Valued At Over 5.5 Million Euros * Improvements Will Include Leak Detection, Water Savings and Guarantee of Supply to End Users MADRID, Spain, July 12,...
-
LOS ANGELES, July 12, 2007 (PRIME NEWSWIRE) -- j2 Global Communications, Inc. (Nasdaq:JCOM), the provider of outsourced, value-added messaging and communications services, invites the public, members...
-
DALLAS, July 12, 2007 (PRIME NEWSWIRE) -- John Pentony, publisher of StockGuru.com, announced today that the web site is initiating profile coverage of Monster Motors, Inc. (Pink Sheets:MRMT). Monster...
-
ANAHEIM, Calif., July 12, 2007 (PRIME NEWSWIRE) -- Pacific Sunwear of California, Inc. (Nasdaq:PSUN) today reported that total sales for the five weeks of fiscal June ended July 7, 2007 were $132.9...
-
TORRANCE, Calif., July 12, 2007 (PRIME NEWSWIRE) -- Execute Sports Inc. (OTCBB:EXCS) today announced that second quarter internet sales have increased 26% over same period 2006. Internet sales for the...
-
EXCHANGE NOTICE 351/2007, 12 JULY 2007 COVERED WARRANTS COVERED WARRANT LISTING ON 16 JULY 2007 The following covered warrant will be listed as of 16 July 2007. The issuer is Commerzbank...
-
Lotus Pharmaceuticals Announces Effective Treatment for Hepatitis B Advances to Reach Chinese Market
BEIJING, July 12, 2007 (PRIME NEWSWIRE) -- Lotus Pharmaceuticals, Inc. (OTCBB:LTUS) announced important developments in the formulation of a Hepatitis B drug that could add an additional $6 million...